Literature DB >> 7514190

Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.

D L Eizirik1, S Sandler, N Welsh, M Cetkovic-Cvrlje, A Nieman, D A Geller, D G Pipeleers, K Bendtzen, C Hellerström.   

Abstract

Cytokines have been proposed as inducers of beta-cell damage in human insulin-dependent diabetes mellitus via the generation of nitric oxide (NO). This concept is mostly based on data obtained in rodent pancreatic islets using heterologous cytokine preparations. The present study examined whether exposure of human pancreatic islets to different cytokines induces NO and impairs beta-cell function. Islets from 30 human pancreata were exposed for 6-144 h to the following human recombinant cytokines, alone or in combination: IFN-gamma (1,000 U/ml), TNF-alpha (1,000 U/ml), IL-6 (25 U/ml), and IL-1 beta (50 U/ml). After 48 h, none of the cytokines alone increased islet nitrite production, but IFN-gamma induced a 20% decrease in glucose-induced insulin release. Combinations of cytokines, notably IL-1 beta plus IFN-gamma plus TNF-alpha, induced increased expression of inducible NO synthase mRNA after 6 h and resulted in a fivefold increase in medium nitrite accumulation after 48 h. These cytokines did not impair glucose metabolism or insulin release in response to 16.7 mM glucose, but there was an 80% decrease in islet insulin content. An exposure of 144 h to IL-1 beta plus IFN-gamma plus TNF-alpha increased NO production and decreased both glucose-induced insulin release and insulin content. Inhibitors of NO generation, aminoguanidine or NG-nitro-L-arginine, blocked this cytokine-induced NO generation, but did not prevent the suppressive effect of IL-1 beta plus IFN-gamma plus TNF-alpha on insulin release and content. In conclusion, isolated human islets are more resistant to the suppressive effects of cytokines and NO than isolated rodent islets. Moreover, the present study suggests that NO is not the major mediator of cytokine effects on human islets.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514190      PMCID: PMC294304          DOI: 10.1172/JCI117188

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Defective catabolism of D-glucose and L-glutamine in mouse pancreatic islets maintained in culture after streptozotocin exposure.

Authors:  D L Eizirik; S Sandler; A Sener; W J Malaisse
Journal:  Endocrinology       Date:  1988-08       Impact factor: 4.736

2.  Determination of total serum insulin (IRI) in insulin-treated diabetic patients.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1972-08       Impact factor: 10.122

Review 3.  Type I diabetes mellitus. A chronic autoimmune disease.

Authors:  G S Eisenbarth
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

4.  Detection of tumour necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay.

Authors:  A Fomsgaard; H Worsaae; K Bendtzen
Journal:  Scand J Immunol       Date:  1988-02       Impact factor: 3.487

Review 5.  Repair of pancreatic beta-cells. A relevant phenomenon in early IDDM?

Authors:  D L Eizirik; S Sandler; J P Palmer
Journal:  Diabetes       Date:  1993-10       Impact factor: 9.461

6.  Viability tests of cryopreserved endocrine pancreatic cells.

Authors:  A Andersson; S Sandler
Journal:  Cryobiology       Date:  1983-04       Impact factor: 2.487

7.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

8.  Production of hybridoma growth factor by human monocytes.

Authors:  L A Aarden; E R De Groot; O L Schaap; P M Lansdorp
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

9.  Inhibitor of interleukin 1 in normal human urine. Different effects on mouse thymocytes and on a murine T-cell line.

Authors:  M Svenson; K Bendtzen
Journal:  Scand J Immunol       Date:  1988-05       Impact factor: 3.487

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  85 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets.

Authors:  T Linn; J Schmitz; I Hauck-Schmalenberger; Y Lai; R G Bretzel; H Brandhorst; D Brandhorst
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

3.  The nuclear orphan receptor Nur77 is a lipotoxicity sensor regulating glucose-induced insulin secretion in pancreatic β-cells.

Authors:  Olivier Briand; Audrey Helleboid-Chapman; Maheul Ploton; Nathalie Hennuyer; Rodolphe Carpentier; François Pattou; Brigitte Vandewalle; Ericka Moerman; Valery Gmyr; Julie Kerr-Conte; Jérôme Eeckhoute; Bart Staels; Philippe Lefebvre
Journal:  Mol Endocrinol       Date:  2012-02-02

4.  Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets.

Authors:  P Ylipaasto; B Kutlu; S Rasilainen; J Rasschaert; K Salmela; H Teerijoki; O Korsgren; R Lahesmaa; T Hovi; D L Eizirik; T Otonkoski; M Roivainen
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

5.  Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and function.

Authors:  Xiangxu Jia; Kun Cheng; Ram I Mahato
Journal:  Mol Pharm       Date:  2007-01-26       Impact factor: 4.939

6.  A novel inhibitor of inducible NOS dimerization protects against cytokine-induced rat beta cell dysfunction.

Authors:  Linlin Zhong; Tuan Tran; Tyler D Baguley; Sang Jun Lee; Adam Henke; Andrew To; Sijia Li; Shan Yu; Fabio A Grieco; Jason Roland; Peter G Schultz; Decio L Eizirik; Nikki Rogers; Arnab K Chartterjee; Matthew S Tremblay; Weijun Shen
Journal:  Br J Pharmacol       Date:  2018-07-14       Impact factor: 8.739

Review 7.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

Review 8.  New insights into the role of connexins in pancreatic islet function and diabetes.

Authors:  Nikki L Farnsworth; Richard K P Benninger
Journal:  FEBS Lett       Date:  2014-02-28       Impact factor: 4.124

9.  Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.

Authors:  Hideaki Kaneto; Taka-Aki Matsuoka; Yoshihisa Nakatani; Dan Kawamori; Takeshi Miyatsuka; Munehide Matsuhisa; Yoshimitsu Yamasaki
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

10.  A combined "omics" approach identifies N-Myc interactor as a novel cytokine-induced regulator of IRE1 protein and c-Jun N-terminal kinase in pancreatic beta cells.

Authors:  Flora Brozzi; Sarah Gerlo; Fabio Arturo Grieco; Tarlliza Romanna Nardelli; Sam Lievens; Conny Gysemans; Lorella Marselli; Piero Marchetti; Chantal Mathieu; Jan Tavernier; Décio L Eizirik
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.